Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | AQUA PHARMA | 1 | ₹24.1 L |
| 2 | Schedule 2 | SUNIL PHARMACY | 1 | ₹16,250.40 |
| 3 | Schedule 3 | SUNIL PHARMACY | 1 | ₹1,029 |
| 4 | Schedule 4 | R.I. PHARAMACEUTICALS | 1 | ₹5,400 |
| 5 | Schedule 5 | SMPL LIFE SCIENCES PRIVATE LIMITED | 1 | ₹2.1 L |
Tender Value
₹42.4 L
EMD Value
Exempted
Closing Date
2 Jan 2024, 12:00 pmClosed
Drugs and
5699947
GEM/2023/B/4303896
Two Packet Bid
Rabies Immune Globulin Human USP Heat Treated Ampoule Ampoule containing not less than 150 IU per m
30 days
Ladakh; Leh Ladakh
Item wise evaluation
BOQ
6 documents required · 6 mandatory
2 yrs
₹3
20%
Exempted
2 Jan 2024
18 Dec 2023
2 Jan 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Rabies Immune Globulin Human USP Heat Treated Ampoule Ampoule containing not less than 150 IU per ml of human anti rabies immunoglobulin 2 ml ampoule or PFS | 981 | Vial | Leh | 30 |
| 2 | Indomethacin 75 mg SR Tab | 10,980 | No | Leh | 30 |
| 3 | Digoxin 0 point 5 mg 2 ml Inj | 105 | Amp | Leh | 30 |
| 4 | 2 percent Sertaconazole cream 30 gm tube | 150 | Tube | Leh | 30 |
| 5 | Framycetin sulphate cream BP 1 percent cream 20 gms | 5,820 | Tube | Leh | 30 |
| 6 | Moxifloxacin 0 point 5 percent preservative free Eye drops | 3,015 | Bott | Leh | 30 |
| 7 | Levosulpiride 25 mg Tab | 450 | No | Leh | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5699947.pdf
GEM_BID
gem_17_itmspction_2023-12-06-17-38-17_917fcccccd725e189165c0e4f09a2407.pdf
BOQ
boq_gem_01_2023-12-06-17-38-17_ecc90d82d99fa3725af8fff91abe0184.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .